Trisha Wise-draper

This phase 2 trial tests whether adding metformin, a common diabetes drug, to the immunotherapy pembrolizumab (Keytruda) can help shrink tumors in people with metastatic head and neck cancer. The study enrolls 21 adults whose cancer has spread or returned and cannot be treated wi…

This phase 2 trial tests whether amivantamab can shrink tumors or slow disease in 21 people with recurrent or metastatic adenoid cystic carcinoma, a rare salivary gland cancer. Participants receive weekly or biweekly infusions of the drug. The main goal is to see how many patient…

This phase 2 trial is testing whether adding the immunotherapy drug pembrolizumab (Keytruda) to standard treatment—surgery, radiation, and sometimes chemotherapy—can help people with head and neck cancer live longer without the cancer returning. About 96 participants will receive…